Cargando…

Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery

Objectives Head and neck soft tissue sarcomas (HNSTSs) are a heterogeneous group of rare tumors. Surgical resection with negative margins remains the standard primary treatment for patients with HNSTS. The role of chemotherapy (CT) and radiotherapy (RT) remains controversial. In this multicenter stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Akagündüz, Baran, Akin Telli, Tugba, Sezgin Goksu, Sema, Yildirim, Hasan Cagri, Ozer, Muhammet, Göktaş Aydin, Sabin, Ozyurt, Neslihan, Karacin, Cengiz, Paydas, Semra, Dogan, Mutlu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958307/
https://www.ncbi.nlm.nih.gov/pubmed/33738167
http://dx.doi.org/10.7759/cureus.13324
_version_ 1783664801450295296
author Akagündüz, Baran
Akin Telli, Tugba
Sezgin Goksu, Sema
Yildirim, Hasan Cagri
Ozer, Muhammet
Göktaş Aydin, Sabin
Ozyurt, Neslihan
Karacin, Cengiz
Paydas, Semra
Dogan, Mutlu
author_facet Akagündüz, Baran
Akin Telli, Tugba
Sezgin Goksu, Sema
Yildirim, Hasan Cagri
Ozer, Muhammet
Göktaş Aydin, Sabin
Ozyurt, Neslihan
Karacin, Cengiz
Paydas, Semra
Dogan, Mutlu
author_sort Akagündüz, Baran
collection PubMed
description Objectives Head and neck soft tissue sarcomas (HNSTSs) are a heterogeneous group of rare tumors. Surgical resection with negative margins remains the standard primary treatment for patients with HNSTS. The role of chemotherapy (CT) and radiotherapy (RT) remains controversial. In this multicenter study, we aimed to demonstrate the real-world assessing prognostic factors and the effect of adjuvant treatment modalities in adult patients with HNSTS treated with upfront surgery. Methods We included a total of 47 patients who underwent curative-intent resection of a primary HNSTS between 2000 and 2019. Results The median follow-up was 29 months. The median age of patients was 51 years, and 66% of patients were male. The median relapse-free survival (RFS) of the study population was 31 months (range: 1.0-61.1 months), and the median overall survival (OS) was 115 months (range: 60.8-169.2 months). The univariable analysis revealed that treatment modalities showed a significant impact on RFS (p = 0.021); however, no difference was found in its impact on OS (p = 0.137). R0 resection did not showed impact on RFS (p = 0.130), but a significant association was found with OS (p = 0.004). In multivariable analysis, T stage of the tumor (hazard ratio [HR]: 3.834; 95% CI: 1.631-9.008; p = 0.002) and treatment with surgery and sequential RT and CT (HR: 0.115; 95% CI: 0.035-0.371; p < 0.001) were independent factors associated with RFS. R0 resection was independently associated with OS (HR: 4.902; 95% CI: 1.301-18.465; p = 0.019). Conclusion Our study revealed that R0 resection improved OS, and T3-4 stage of tumor was a negative independent factor for RFS in surgically resected HNSTS patients. The use of sequential CT and RT after resection was associated with a better RFS, which emphasizes the importance of multidisciplinary evaluation of the treatment of HNSTS. Randomized prospective studies are needed
format Online
Article
Text
id pubmed-7958307
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-79583072021-03-17 Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery Akagündüz, Baran Akin Telli, Tugba Sezgin Goksu, Sema Yildirim, Hasan Cagri Ozer, Muhammet Göktaş Aydin, Sabin Ozyurt, Neslihan Karacin, Cengiz Paydas, Semra Dogan, Mutlu Cureus Radiation Oncology Objectives Head and neck soft tissue sarcomas (HNSTSs) are a heterogeneous group of rare tumors. Surgical resection with negative margins remains the standard primary treatment for patients with HNSTS. The role of chemotherapy (CT) and radiotherapy (RT) remains controversial. In this multicenter study, we aimed to demonstrate the real-world assessing prognostic factors and the effect of adjuvant treatment modalities in adult patients with HNSTS treated with upfront surgery. Methods We included a total of 47 patients who underwent curative-intent resection of a primary HNSTS between 2000 and 2019. Results The median follow-up was 29 months. The median age of patients was 51 years, and 66% of patients were male. The median relapse-free survival (RFS) of the study population was 31 months (range: 1.0-61.1 months), and the median overall survival (OS) was 115 months (range: 60.8-169.2 months). The univariable analysis revealed that treatment modalities showed a significant impact on RFS (p = 0.021); however, no difference was found in its impact on OS (p = 0.137). R0 resection did not showed impact on RFS (p = 0.130), but a significant association was found with OS (p = 0.004). In multivariable analysis, T stage of the tumor (hazard ratio [HR]: 3.834; 95% CI: 1.631-9.008; p = 0.002) and treatment with surgery and sequential RT and CT (HR: 0.115; 95% CI: 0.035-0.371; p < 0.001) were independent factors associated with RFS. R0 resection was independently associated with OS (HR: 4.902; 95% CI: 1.301-18.465; p = 0.019). Conclusion Our study revealed that R0 resection improved OS, and T3-4 stage of tumor was a negative independent factor for RFS in surgically resected HNSTS patients. The use of sequential CT and RT after resection was associated with a better RFS, which emphasizes the importance of multidisciplinary evaluation of the treatment of HNSTS. Randomized prospective studies are needed Cureus 2021-02-13 /pmc/articles/PMC7958307/ /pubmed/33738167 http://dx.doi.org/10.7759/cureus.13324 Text en Copyright © 2021, Akagündüz et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Akagündüz, Baran
Akin Telli, Tugba
Sezgin Goksu, Sema
Yildirim, Hasan Cagri
Ozer, Muhammet
Göktaş Aydin, Sabin
Ozyurt, Neslihan
Karacin, Cengiz
Paydas, Semra
Dogan, Mutlu
Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery
title Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery
title_full Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery
title_fullStr Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery
title_full_unstemmed Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery
title_short Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery
title_sort assessment of prognostic factors and adjuvant treatment modalities in adult head and neck soft tissue sarcoma patients treated with upfront surgery
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958307/
https://www.ncbi.nlm.nih.gov/pubmed/33738167
http://dx.doi.org/10.7759/cureus.13324
work_keys_str_mv AT akagunduzbaran assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery
AT akintellitugba assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery
AT sezgingoksusema assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery
AT yildirimhasancagri assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery
AT ozermuhammet assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery
AT goktasaydinsabin assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery
AT ozyurtneslihan assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery
AT karacincengiz assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery
AT paydassemra assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery
AT doganmutlu assessmentofprognosticfactorsandadjuvanttreatmentmodalitiesinadultheadandnecksofttissuesarcomapatientstreatedwithupfrontsurgery